Reaction

Infrequent Bowel Movements reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,463 reports · 50 co-occurring drugs

As of the last recalculation, Infrequent Bowel Movements appears in 2,463 FAERS reports alongside 50 co-occurring drug terms. The strongest observed disproportionality signal is ORLISTAT (PRR 33.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Orlistat	98	33.3	33.4
Linaclotide	70	22.8	22.8
Loperamide Hydrochloride And Dimethicone	80	21.8	21.8
Teduglutide	27	17.1	17.1
Loperamide Hydrochloride	71	13.8	13.8
Polyethylene Glycol 3350	138	12.9	12.9
Primidone	15	12.5	12.5
Cimetidine	14	12.3	12.4
Dimenhydrinate	15	12.0	12.0
Rotigotine	20	11.8	11.8
Octreotide Acetate	42	11.8	11.8
Exenatide	66	10.9	10.9
Rivastigmine	24	10.9	10.9
Psyllium Husk	11	9.4	9.5
Magnesium Hydroxide	14	8.8	8.8
Quinapril Hydrochloride	8	8.6	8.6
Cyanocobalamin	32	8.3	8.3
Cholestyramine	11	7.7	7.7
Mesalamine	47	7.2	7.2
Lubiprostone	8	7.2	7.2
Levodopa	10	7.0	7.0
Niraparib	18	6.9	6.9
Ropinirole	12	6.6	6.6
Lactulose	29	6.5	6.5
Oral Semaglutide	55	6.5	6.5
Infliximab-Dyyb	22	6.4	6.4
Extended Phenytoin Sodium	12	6.1	6.1
Atomoxetine Hydrochloride	17	6.1	6.1
Vedolizumab	58	5.8	5.8
Lanreotide Acetate	5	5.4	5.4
Temozolomide	13	5.2	5.2
Dutasteride	5	5.2	5.2
Diroximel Fumarate	7	5.0	5.0
Carbidopa And Levodopa	26	4.7	4.7
Ivacaftor	4	4.3	4.3
Ozanimod Hydrochloride	4	4.1	4.1
Rifaximin	10	4.0	4.0
Naltrexone Hydrochloride And Bupropion Hydrochloride	4	4.0	4.0
Patiromer	6	3.7	3.7
Dulaglutide	33	3.2	3.2
Clozapine	45	3.1	3.1
Vortioxetine	6	3.0	3.0
Teriparatide	38	2.9	2.9
Acalabrutinib	4	2.8	2.8
Liraglutide	16	2.7	2.7
Elexacaftor, Tezacaftor, And Ivacaftor	4	2.7	2.7
Certolizumab Pegol	36	2.6	2.6
Tirzepatide	43	2.3	2.3
Olaparib	5	2.0	2.0
Relugolix	5	1.8	1.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.